ANI Pharmaceuticals Completes $210m Novitium Acquisition

Acquisition Expected To Bolster R&D, Generics Scale And CDMO Business

Handshake Paper cutouts
ANI has completed its acquisition of Novitium • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business